Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake

Jiwei Cui, Karen Alt, Yi Ju, Sylvia T. Gunawan, Julia A. Braunger, Ting Yi Wang, Yunlu Dai, Qiong Dai, Joseph J. Richardson, Junling Guo, Mattias Björnmalm, Christoph E. Hagemeyer, Frank Caruso

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Drug carriers typically require both stealth and targeting properties to minimize nonspecific interactions with healthy cells and increase specific interaction with diseased cells. Herein, the assembly of targeted poly(ethylene glycol) (PEG) particles functionalized with cyclic peptides containing Arg-Gly-Asp (RGD) (ligand) using a mesoporous silica templating method is reported. The influence of PEG molecular weight, ligand-to-PEG molecule ratio, and particle size on cancer cell targeting to balance stealth and targeting of the engineered PEG particles is investigated. RGD-functionalized PEG particles (PEG-RGD particles) efficiently target U-87 MG cancer cells under static and flow conditions in vitro, whereas PEG and cyclic peptides containing Arg-Asp-Gly (RDG)-functionalized PEG (PEG-RDG) particles display negligible interaction with the same cells. Increasing the ligand-to-PEG molecule ratio improves cell targeting. In addition, the targeted PEG-RGD particles improve cell uptake via receptor-mediated endocytosis, which is desirable for intracellular drug delivery. The PEG-RGD particles show improved tumor targeting (14% ID g-1) when compared with the PEG (3% ID g-1) and PEG-RDG (7% ID g-1) particles in vivo, although the PEG-RGD particles show comparatively higher spleen and liver accumulation. The targeted PEG particles represent a platform for developing particles aimed at balancing nonspecific and specific interactions in biological systems.

Original languageEnglish
Pages (from-to)3592-3600
Number of pages9
JournalBiomacromolecules
Volume20
Issue number9
DOIs
Publication statusPublished - 9 Sep 2019

Cite this

Cui, Jiwei ; Alt, Karen ; Ju, Yi ; Gunawan, Sylvia T. ; Braunger, Julia A. ; Wang, Ting Yi ; Dai, Yunlu ; Dai, Qiong ; Richardson, Joseph J. ; Guo, Junling ; Björnmalm, Mattias ; Hagemeyer, Christoph E. ; Caruso, Frank. / Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake. In: Biomacromolecules. 2019 ; Vol. 20, No. 9. pp. 3592-3600.
@article{2facc1f8d0154c95bf8a868839f22912,
title = "Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake",
abstract = "Drug carriers typically require both stealth and targeting properties to minimize nonspecific interactions with healthy cells and increase specific interaction with diseased cells. Herein, the assembly of targeted poly(ethylene glycol) (PEG) particles functionalized with cyclic peptides containing Arg-Gly-Asp (RGD) (ligand) using a mesoporous silica templating method is reported. The influence of PEG molecular weight, ligand-to-PEG molecule ratio, and particle size on cancer cell targeting to balance stealth and targeting of the engineered PEG particles is investigated. RGD-functionalized PEG particles (PEG-RGD particles) efficiently target U-87 MG cancer cells under static and flow conditions in vitro, whereas PEG and cyclic peptides containing Arg-Asp-Gly (RDG)-functionalized PEG (PEG-RDG) particles display negligible interaction with the same cells. Increasing the ligand-to-PEG molecule ratio improves cell targeting. In addition, the targeted PEG-RGD particles improve cell uptake via receptor-mediated endocytosis, which is desirable for intracellular drug delivery. The PEG-RGD particles show improved tumor targeting (14{\%} ID g-1) when compared with the PEG (3{\%} ID g-1) and PEG-RDG (7{\%} ID g-1) particles in vivo, although the PEG-RGD particles show comparatively higher spleen and liver accumulation. The targeted PEG particles represent a platform for developing particles aimed at balancing nonspecific and specific interactions in biological systems.",
author = "Jiwei Cui and Karen Alt and Yi Ju and Gunawan, {Sylvia T.} and Braunger, {Julia A.} and Wang, {Ting Yi} and Yunlu Dai and Qiong Dai and Richardson, {Joseph J.} and Junling Guo and Mattias Bj{\"o}rnmalm and Hagemeyer, {Christoph E.} and Frank Caruso",
year = "2019",
month = "9",
day = "9",
doi = "10.1021/acs.biomac.9b00925",
language = "English",
volume = "20",
pages = "3592--3600",
journal = "Biomacromolecules",
issn = "1525-7797",
publisher = "American Chemical Society (ACS)",
number = "9",

}

Cui, J, Alt, K, Ju, Y, Gunawan, ST, Braunger, JA, Wang, TY, Dai, Y, Dai, Q, Richardson, JJ, Guo, J, Björnmalm, M, Hagemeyer, CE & Caruso, F 2019, 'Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake', Biomacromolecules, vol. 20, no. 9, pp. 3592-3600. https://doi.org/10.1021/acs.biomac.9b00925

Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake. / Cui, Jiwei; Alt, Karen; Ju, Yi; Gunawan, Sylvia T.; Braunger, Julia A.; Wang, Ting Yi; Dai, Yunlu; Dai, Qiong; Richardson, Joseph J.; Guo, Junling; Björnmalm, Mattias; Hagemeyer, Christoph E.; Caruso, Frank.

In: Biomacromolecules, Vol. 20, No. 9, 09.09.2019, p. 3592-3600.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake

AU - Cui, Jiwei

AU - Alt, Karen

AU - Ju, Yi

AU - Gunawan, Sylvia T.

AU - Braunger, Julia A.

AU - Wang, Ting Yi

AU - Dai, Yunlu

AU - Dai, Qiong

AU - Richardson, Joseph J.

AU - Guo, Junling

AU - Björnmalm, Mattias

AU - Hagemeyer, Christoph E.

AU - Caruso, Frank

PY - 2019/9/9

Y1 - 2019/9/9

N2 - Drug carriers typically require both stealth and targeting properties to minimize nonspecific interactions with healthy cells and increase specific interaction with diseased cells. Herein, the assembly of targeted poly(ethylene glycol) (PEG) particles functionalized with cyclic peptides containing Arg-Gly-Asp (RGD) (ligand) using a mesoporous silica templating method is reported. The influence of PEG molecular weight, ligand-to-PEG molecule ratio, and particle size on cancer cell targeting to balance stealth and targeting of the engineered PEG particles is investigated. RGD-functionalized PEG particles (PEG-RGD particles) efficiently target U-87 MG cancer cells under static and flow conditions in vitro, whereas PEG and cyclic peptides containing Arg-Asp-Gly (RDG)-functionalized PEG (PEG-RDG) particles display negligible interaction with the same cells. Increasing the ligand-to-PEG molecule ratio improves cell targeting. In addition, the targeted PEG-RGD particles improve cell uptake via receptor-mediated endocytosis, which is desirable for intracellular drug delivery. The PEG-RGD particles show improved tumor targeting (14% ID g-1) when compared with the PEG (3% ID g-1) and PEG-RDG (7% ID g-1) particles in vivo, although the PEG-RGD particles show comparatively higher spleen and liver accumulation. The targeted PEG particles represent a platform for developing particles aimed at balancing nonspecific and specific interactions in biological systems.

AB - Drug carriers typically require both stealth and targeting properties to minimize nonspecific interactions with healthy cells and increase specific interaction with diseased cells. Herein, the assembly of targeted poly(ethylene glycol) (PEG) particles functionalized with cyclic peptides containing Arg-Gly-Asp (RGD) (ligand) using a mesoporous silica templating method is reported. The influence of PEG molecular weight, ligand-to-PEG molecule ratio, and particle size on cancer cell targeting to balance stealth and targeting of the engineered PEG particles is investigated. RGD-functionalized PEG particles (PEG-RGD particles) efficiently target U-87 MG cancer cells under static and flow conditions in vitro, whereas PEG and cyclic peptides containing Arg-Asp-Gly (RDG)-functionalized PEG (PEG-RDG) particles display negligible interaction with the same cells. Increasing the ligand-to-PEG molecule ratio improves cell targeting. In addition, the targeted PEG-RGD particles improve cell uptake via receptor-mediated endocytosis, which is desirable for intracellular drug delivery. The PEG-RGD particles show improved tumor targeting (14% ID g-1) when compared with the PEG (3% ID g-1) and PEG-RDG (7% ID g-1) particles in vivo, although the PEG-RGD particles show comparatively higher spleen and liver accumulation. The targeted PEG particles represent a platform for developing particles aimed at balancing nonspecific and specific interactions in biological systems.

UR - http://www.scopus.com/inward/record.url?scp=85071899342&partnerID=8YFLogxK

U2 - 10.1021/acs.biomac.9b00925

DO - 10.1021/acs.biomac.9b00925

M3 - Article

VL - 20

SP - 3592

EP - 3600

JO - Biomacromolecules

JF - Biomacromolecules

SN - 1525-7797

IS - 9

ER -